HD-OPM Archive
Topics › Statins

Statin use linked to 45% lower mortality in leukemia/lymphoma patients (CLL/SLL)

Louis Nervegna · Apr 29, 2025 · ♥ 7 reactions · 1 comments · original Facebook post
StatinsCancer
AI summary & key facts

Medscape item on a study in chronic lymphocytic leukemia and small lymphocytic lymphoma where statin use was associated with better survival, with no increase in severe adverse effects. Observational and outside the heart-disease focus.

(no text — see the shared post below)

Research cited

Shared from Medscape · original post

Statin use in patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) was associated with significant survival benefits, with a 45% lower risk for overall mortality and 27% reduced risk for disease progression. Benefits remained consistent across treatment types, with no increase in severe adverse effects. Patients Benefit From Statin-Ibrutinib Combo (Medscape)

No photo description available.
#statins#mortality
← newer: Eur Heart J 2025: apoB particle count, not size or type, driolder: 'Uncured' and 'nitrate-free' processed meats still use nitra →